Macrolide Susceptibility and β-Lactamase Production among Haemophilus influenzae Isolates in the United States, 1996–1997

Tekijä Hogan, Patricia A., Sheehan, Daniel J.
Julkaistu 1998

Current and Emerging Azole Antifungal Agents

Tekijä Sheehan, Daniel J., Hitchcock, Christopher A., Sibley, Carol M.
Julkaistu 1999

Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

Tekijä Styers, David, Sheehan, Daniel J, Hogan, Patricia, Sahm, Daniel F
Julkaistu 2006

In Vitro Activity of Linezolid against Key Gram-Positive Organisms Isolated in the United States: Results of the LEADER 2004 Surveillance Program

Tekijä Draghi, Deborah C., Sheehan, Daniel J., Hogan, Patricia, Sahm, Daniel F.
Julkaistu 2005

Combination Treatment of Invasive Fungal Infections

Tekijä Mukherjee, Pranab K., Sheehan, Daniel J., Hitchcock, Christopher A., Ghannoum, Mahmoud A.
Julkaistu 2005

Activity of Linezolid against 3,251 Strains of Uncommonly Isolated Gram-Positive Organisms: Report from the SENTRY Antimicrobial Surveillance Program

Tekijä Jones, Ronald N., Stilwell, Matthew G., Hogan, Patricia A., Sheehan, Daniel J.
Julkaistu 2007

Activity of Anidulafungin in a Murine Model of Candida krusei Infection: Evaluation of Mortality and Disease Burden by Quantitative Tissue Cultures and Measurement of Serum (1,3)-β...

Tekijä Ostrosky-Zeichner, Luis, Paetznick, Victor L., Rodriguez, Jose, Chen, Enuo, Sheehan, Daniel J.
Julkaistu 2009

Selection of a Surrogate Agent (Vancomycin or Teicoplanin) for Initial Susceptibility Testing of Dalbavancin: Results from an International Antimicrobial Surveillance Program

Tekijä Jones, Ronald N., Sader, Helio S., Fritsche, Thomas R., Hogan, Patricia A., Sheehan, Daniel J.
Julkaistu 2006

Bactericidal Activity and Resistance Development Profiling of Dalbavancin

Tekijä Goldstein, Beth P., Draghi, Deborah C., Sheehan, Daniel J., Hogan, Patricia, Sahm, Daniel F.
Julkaistu 2007

ABNORMAL AQUAPORIN-3 PROTEIN EXPRESSION IN HYPERPROLIFERATIVE SKIN DISORDERS

Tekijä Voss, Kristen E., Bollag, Roni J., Fussell, Nicole, By, Charya, Sheehan, Daniel J., Bollag, Wendy B.
Julkaistu 2011

Lasp1 gene disruption is linked to enhanced cell migration and tumor formation

Tekijä Zhang, Han, Chen, Xunsheng, Bollag, Wendy B., Bollag, Roni J., Sheehan, Daniel J., Chew, Catherine S.
Julkaistu 2009

Comparison of High-Performance Liquid Chromatographic and Microbiological Methods for Determination of Voriconazole Levels in Plasma

Tekijä Perea, Sofia, Pennick, Gennethel J., Modak, Asha, Fothergill, Annette W., Sutton, Deanna A., Sheehan, Daniel J., Rinaldi, Michael G.
Julkaistu 2000

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

Tekijä Rex, John H., Pfaller, Michael A., Walsh, Thomas J., Chaturvedi, Vishnu, Espinel-Ingroff, Ana, Ghannoum, Mahmoud A., Gosey, Linda L., Odds, Frank C., Rinaldi, Michael G., Sheehan, Daniel J., Warnock, David W.
Julkaistu 2001

Rationale for Reading Fluconazole MICs at 24 Hours Rather than 48 Hours When Testing Candida spp. by the CLSI M27-A2 Standard Method

Tekijä Ostrosky-Zeichner, Luis, Rex, John H., Pfaller, Michael A., Diekema, Daniel J., Alexander, Barbara D., Andes, David, Brown, Steven D., Chaturvedi, Vishnu, Ghannoum, Mahmoud A., Knapp, Cindy C., Sheehan, Daniel J., Walsh, Thomas J.
Julkaistu 2008